GL1X · GenesisL1 explorer

MolNFT v1 · #182918 · protein

Pptt PAP(COA) 8978B complex

7N8M · 4'-phosphopantetheinyl transferase pptt: “Pptt PAP(COA) 8978B complex”. X-ray diffraction, 3 ligands (17I, COA, MG), 3 pockets (best druggability 0.71). MolNFT v1 #182918 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7N8M
Type
protein
Length
442 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
4'-phosphopantetheinyl transferase pptt
EC
2.7.8.7
UniProt
O33336
Ligands
17I, COA, MG
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B4'-phosphopantetheinyl transferase pptt (EC 2.7.8.7)protein22130% helix, 29% strandO33336

Ligands and binding sites

  • 17I · N-(2,6-diethylphenyl)-N'-(N-methylcarbamimidoyl)urea · ligand · 3 copies · chains A, B
  • COA · Coenzyme A · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 7 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 4 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15060.710.8061COA, 17I, MG, GOL
23990.680.8048COA, 17I, MG
31020.360.7418empty

Interfaces

1 interface between chains.

  • A–B · 338 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 7N8M · PptT PAP(CoA) 8978B complex · the same entry in another collection · chain A against A, TM-score 1.00
  • O33336 · AlphaFold monomer V2.0 prediction for 4'-phosphopantetheinyl transferase pptt (O33336) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.